scholarly journals Phase II study of TAS-116, an oral inhibitor of heat shock protein 90 (HSP90), in metastatic or unresectable gastrointestinal stromal tumor refractory to imatinib, sunitinib and regorafenib

2017 ◽  
Vol 28 ◽  
pp. v322-v323 ◽  
Author(s):  
Y. Kurokawa ◽  
T. Doi ◽  
A. Sawaki ◽  
Y. Komatsu ◽  
M. Ozaka ◽  
...  
Keyword(s):  
Heat Shock ◽  
Heat Shock Protein ◽  
Gastrointestinal Stromal Tumor ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Heat Shock Protein 90 ◽  
Stromal Tumor

scholarly journals STI571 (Glivec) inhibits the interaction between c-KIT and heat shock protein 90 of the gastrointestinal stromal tumor cell line, GIST-T1

2005 ◽  
Vol 96 (2) ◽  
pp. 116-119 ◽  
Author(s):  
Hajime Nakatani ◽  
Michiya Kobayashi ◽  
Toufeng Jin ◽  
Takahiro Taguchi ◽  
Takeki Sugimoto ◽  
...  
Keyword(s):  
Heat Shock ◽  
Heat Shock Protein ◽  
Tumor Cell ◽  
Gastrointestinal Stromal Tumor ◽  
Cell Line ◽  
Tumor Cell Line ◽  
Heat Shock Protein 90 ◽  
Stromal Tumor

scholarly journals Heat Shock Protein 90 Inhibition in Imatinib-Resistant Gastrointestinal Stromal Tumor

2006 ◽  
Vol 66 (18) ◽  
pp. 9153-9161 ◽  
Author(s):  
Sebastian Bauer ◽  
Lynn K. Yu ◽  
George D. Demetri ◽  
Jonathan A. Fletcher
Keyword(s):  
Heat Shock ◽  
Heat Shock Protein ◽  
Gastrointestinal Stromal Tumor ◽  
Heat Shock Protein 90 ◽  
Stromal Tumor ◽  
Imatinib Resistant

scholarly journals Regorafenib as second line therapy for imatinib-resistant gastrointestinal stromal tumor (GIST): A phase II study

2019 ◽  
Vol 30 ◽  
pp. vi88
Author(s):  
Yoichi Naito ◽  
Toshihiko Doi ◽  
Tsuyoshi Takahashi ◽  
Toshihiro Kudo ◽  
Narikazu Boku ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumor ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Stromal Tumor ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Imatinib Resistant
Sign in / Sign up

Export Citation Format

Share Document